Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Explore Which Indices Move This Week and the key drivers behind recent changes. The section offers concise observations to help readers interpret market dynamics.
26,181 articlesRevolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Rivian remains valued far below Ford despite big hype around electric-vehicle startups. With Rivian’s deliveries risi...
Super Micro Computer stock tumbled 29% in a month as Dell and HPE rally on AI growth. Analysts weigh whether investor...
James Murdoch’s early SpaceX investment could translate into a multi-billion-dollar windfall, depending on private-ma...
Real Brokerage and REMAX will vote virtually on August 14 to approve a merger that would create the Real REMAX Group....
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
Netflix revealed it used AI to speed production on a documentary, delivering 17 minutes of AI-enhanced footage at hal...
AI-driven data centers are keeping DRAM prices high as demand for high-bandwidth memory tightens supply. Market obser...
A wave of cheaper AI models is reshaping demand for hardware, boosting NVIDIA, Micron, and SanDisk as investors weigh...
Zircuit Finance unveils an institutional-grade on-chain yield vault designed to deliver 8-11% APR, combining cross-ch...
As Appian reports Q4 2025 results, investors reassess growth, profitability, and long-term value. This guide breaks d...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...